MortensenMERennebohmRM. Clinical pharmacology and use of nonsteroidal antiinflammatory drugs. Pediatr Clin North Am1989; 36: 1113–39.
2.
SandlerDPBurrRWeinbergCR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med1991; 115: 165–72.
3.
GalPRansomJLSchallSWeaverRLBirdABrownY. Indomethacin for patent ductus arteriosus: Application of serum concentrations and pharmacodynamics to improve response. J Perinatal1990; 10: 20–6.
4.
Intracranial hemorrhage of the premature infant. In: VolpeJJ. Neurology of the newborn. Major problems in clinical pediatrics. Vol. 22, 2nd ed.Philadelphia: WB Saunders, 1987: 311–61.
5.
PapileLA. Periventricular-intraventricular hemorrhage in the extremely-low-birth-weight infant. In: The micropremie: The next frontier. Report of the 99th Ross Conference on Pediatric Research. Columbus, OH: Ross Laboratories, 1990: 145–54.
6.
PapileLAMunsick-BrunoGSchaeferA. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr1983; 103: 273–7.
7.
PerlmanJMGoodmanSKreusserKLVolpeJJ. Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome. N Engl J Med1985; 312: 1353–7.
8.
MentLRStewartWBScottDTDuncanCC. Beagle puppy model of intraventricular hemorrhage: Randomized indomethacin prevention trial. Neurology1983; 33: 179–84.
9.
LefflerCWBusijaDWFletcherAWBeasleyDGMesslerJRGreenRS. Effect of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res1985; 19: 1160–4.
10.
MentLRDuncanCCEhrenkranzRARandomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr1985; 107: 937–43.
11.
MentLRDuncanCCEhrenkranzRA. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr1988; 112: 948–55.
12.
BandstraESMontalvoBMGoldbergRNProphylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics1988; 82: 533–42.
13.
BadaHSGreenRPourcyrousMIndomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr1989; 115: 631–7.
14.
HaniganWCKennedyGRoemischF. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr1988; 112: 941–7.
15.
SzymonowicaWYuVYH. Periventricular hemorrhage: Association with patent ductus arteriosus and its treatment with indomethacin or surgery. Aust Paediatr J1986; 23: 21–5.
16.
DavisJMHendricks-MunozKDHagbergDManningJA. The effect of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus. Dev Pharmacol Ther1990; 14: 15–9.
17.
YehTFWilksALukenJPildesRS. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria. Dev Pharmacol Ther1986; 9: 369–74.
18.
GalPRansomJLWeaverRLSchallSBrownY. Impact of concurrent furosemide on indomethacin pharmacodynamics re: Efficacy of PDA closure and renal toxicity (abstract). Pharmacotherapy1990; 10: 238.